PARD3 antibody (C-Term)
Quick Overview for PARD3 antibody (C-Term) (ABIN453777)
Target
See all PARD3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- This antibody reacts to PARD3.
-
Purification
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide selected from the C-terminal region of human PARD3
-
-
-
-
Application Notes
-
ELISA: 1/1,000. Western blotting: 1/100 - 1/500.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PARD3 (Par-3 Partitioning Defective 3 Homolog (PARD3))
-
Alternative Name
- PARD3 / PAR3
-
Background
- PARD proteins, which were first identified in C. elegans, are essential for asymmetric cell division and polarized growth, whereas CDC42 (MIM 116952) mediates the establishment of cell polarity. The CDC42 GTPase, which is controlled by nucleotide exchange factors (GEFs, see MIM 606057) and GTPase-activating proteins (GAPs, see MIM 604980), interacts with a large set of effector proteins that typically contain a CDC42/RAC (MIM 602048)-interactive binding (CRIB) domain.Synonyms: ASIP, Atypical PKC isotype-specific-interacting protein, CTCL tumor antigen se2-5, PAR-3, PAR3-alpha, PAR3A, PARD-3, Partitioning defective 3 homolog
-
Gene ID
- 56288
-
NCBI Accession
- NP_062565
-
UniProt
- Q8TEW0
-
Pathways
- Cell-Cell Junction Organization
Target
-